Filing Details
- Accession Number:
- 0001125345-18-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-01 17:24:12
- Reporting Period:
- 2018-02-28
- Accepted Time:
- 2018-03-01 17:24:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587150 | Lynn Cilinski | 9704 Medical Center Drive Rockville MD 20850 | Vp, Controller And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-28 | 7,989 | $0.94 | 9,912 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-02-28 | 7,989 | $0.94 | 17,901 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-02-28 | 7,989 | $1.51 | 25,890 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-28 | 23,967 | $25.01 | 1,923 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee stock option (right to buy) | Disposition | 2018-02-28 | 7,989 | $0.00 | 7,989 | $0.94 |
| Common Stock | Employee stock option (right to buy) | Disposition | 2018-02-28 | 7,989 | $0.00 | 7,989 | $0.94 |
| Common Stock | Employee stock option (right to buy) | Disposition | 2018-02-28 | 7,989 | $0.00 | 7,989 | $1.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-07-09 | 2021-01-08 | No | 4 | M | Direct |
| 0 | 2012-09-14 | 2022-03-13 | No | 4 | M | Direct |
| 0 | 2013-07-06 | 2023-01-05 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2017.
- This transaction was executed in multiple trades at prices ranging from $25.00 to $25.14. The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
